Acumen Pharmaceuticals, Inc. · NASDAQ:ABOS
RA Capital Nexus Fund II, L.P. received 35,500 Acumen Pharmaceuticals, Inc. shares as an award (Form 4)
Traded Jun 3, 2026 · Filed Jun 5, 2026
On Jun 3, 2026, RA Capital Nexus Fund II, L.P. (Director) received 35,500 Acumen Pharmaceuticals, Inc. shares as an award, leaving 48,300 shares. Filed Jun 5, 2026 (Form 4).
- Awarded
- 35,500 shares
- Holding after
- 48,300 shares (held indirectly)
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 3, 2026 | Common Stock | Award | 35,500 | 48,300 | Indirect |
Source
Related
- Acumen Pharmaceuticals, Inc.
- RA Capital Nexus Fund II, L.P.
- Acumen Pharmaceuticals, Inc. shareholders
- Form 4 · Porter Derrell · Jun 17, 2026
- Form 4 · Fountain Nathan B · Jun 10, 2026
- Form 4 · Fountain Nathan B · Jun 5, 2026
- Form 4 · Drapkin Kimberlee C · Jun 5, 2026
- Form 4 · Stalfort John A III · Jun 5, 2026